Champions Oncology, Inc. (CSBR) at a glance

Champions Oncology, Inc. (CSBR) is a micro-cap Healthcare company. It trades at $6.1, with a P/E of 35.9, a -4% profit margin and revenue decline of 2.8%. It does not pay a dividend. Vestovix scores it 37/100 overall. Its strongest dimension is Safety (70/100) and its weakest is Value (15/100). It is a relatively defensive holding with below-market volatility.

Price

$6.10

Market cap

$90.3M

P/E ratio

35.9

Dividend yield

None

Beta

0.40

52-week range

$5.50 to $8.74